Amber Salzman

Amber Salzman

Directeur Général chez
Epicrispr Biotechnologies, Inc.
64 ans
Health Technology
Consumer Services
Commercial Services

Profil

Amber Salzman is the founder of Annapurna Therapeutics SAS, which was founded in 2012.
She held the title of President & Chief Executive Officer from 2012 to 2016.
Currently, she is the President, Chief Executive Officer & Director at Ohana Biosciences, Inc., the Chief Executive Officer at Epicrispr Biotechnologies, Inc., the Director at Drexel University School of Public Health, the Director at Ald Connect, Inc., a Non-Executive Director at AviadoBio Ltd., and a Trustee at Lankenau Institute for Medical Research.
She is also the President of The Stop ALD Foundation since 2001.
In her former positions, she was the President & Chief Executive Officer of CardioKine, Inc. from 2009 to 2011, the President, Chief Executive Officer & Director of Adverum Biotechnologies, Inc. from 2016 to 2018, and a Director at Akcea Therapeutics, Inc. in 2020.
She was also a Member-Research & Development Executive Team at GSK Plc.
Dr. Salzman holds a doctorate degree from Bryn Mawr College and an undergraduate degree from Temple University (Pennsylvania).

Postes actifs de Amber Salzman

SociétésPosteDébut
President 01/03/2001
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur Général -

Anciens postes connus de Amber Salzman

SociétésPosteFin
AKCEA THERAPEUTICS, INC. Directeur/Membre du Conseil 12/10/2020
ADVERUM BIOTECHNOLOGIES, INC. Directeur Général 03/05/2018
Directeur Général 01/01/2016
░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░ -
Voir l'expérience en détail de Amber Salzman

Formation de Amber Salzman

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

33

Relations au 1er degré

14

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées14

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Services

Commercial Services

Health Technology

Commercial Services

  1. Bourse
  2. Insiders
  3. Amber Salzman
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT
🔇